Blepharitis

Ophthalmology·MeSH: Blepharitis

9 drugs in development·4 companies·2 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
XDEMVY (lotilaner ophthalmic solution) 0.25%	Tarsus Pharmaceuticals, Inc. (TARS)

Phase 3(2)

Drug	Company
pimecrolimus 0.3% ophthalmic	Viatris Inc (VTRS)
tp-03	LianBio (LIANY)

Phase 2(1)

Drug	Company
GLK-321 mid dose BID	Crinetics Pharmaceuticals, Inc. (CRNX)

Phase 4(5)

Drug	Company
Lotilaner ophthalmic solution, 0.25%	Tarsus Pharmaceuticals, Inc. (TARS)
TP-04 (novel ophthalmic gel formulation of lotilaner)	Tarsus Pharmaceuticals, Inc. (TARS)
TP-05 (investigational oral tablet formulation of lotilaner)	Tarsus Pharmaceuticals, Inc. (TARS)
TP-05 (novel investigational oral formulation of lotilaner)	Tarsus Pharmaceuticals, Inc. (TARS)
Vehicle control	Tarsus Pharmaceuticals, Inc. (TARS)

BioSniper tracks 9 drugs in development for Blepharitis across 4 companies.

There are 2 clinical trials targeting Blepharitis tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.